35 MS Flashcards

1
Q

MS - multiple sclerosis
- an immune-mediated ( ___ ) disorder involving destruction of the ___ that surrounds neuronal axons

sclerosis - refers to ___ that accumulate in the white matter

A
  • inflammatory
  • myelin sheath
  • scars
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

multiple refers to the numerous affected areas of the CNS producing multiple neurologic symptoms that build up
- no 2 MS patients will exhibit the same profile of symtoms
- a patient’s symptoms may vary markedly during different stages of the disease
- the most prominent symptoms in each patient are a reflection of the regions of the nervous system with the most severe damage

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MS etiology: a potential role for viral infections

viral or bacterial infections may increase the risk of MS by activating autoreactive ___ cells in genetically susceptible individuals
- increased ___ synthesis in the CNS of MS patients
- increased antibody titers to certain viruses
- epidemiological data suggests that ___ infection increases risk

A

immune
IgG
childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MS etiology: a potential role for viral infections

Epstein-Barr Virus (EBV)
- sequence similarities between EBV and ___ result in activation of autoreactive ___ or ___ cells (molecular ___ )
- increased atibody titers to epstein-Barr nuclear antigen (EBNA) in MS patients
- individuals with a particular ___ phenotype have an increased risk of developing MS when they also have anti-EBNA antibodies ( ___ -___ interactions)

A
  • self-peptides,T, B, mimicry
  • HLA
  • gene-environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Different clinical forms of MS

RRMS - ___ MS , 85% of cases
- relapses of neurological dysfunction lasting ___ or ___ and affecting the brain, optic nerves and or spinal cord
- ___ areas of damage are revealed by magnetic resonance imaging, generally (but not always) in the ___ matter
- initial symptoms disappear, but less ___ with each relapse
- most cases eventually enter SPMS

A
  • relapsing-remitting
  • weeks, months
  • multifocal, white
  • remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Different clinical forms of MS

SPMS - ___ MS
- less ____ than RRMS
- involves slowly progressive neurological decline and CNS damage, with little ___

A
  • secondary progressice
  • inflammation
  • remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Different clinical forms of MS

PPMS - ___ MS, 15%
- resembles SPMS at initial stage
- mean age of onset is ___ than RRMS, perhaps because inflammatory episodes of RRMS surpass the symptomatic threshold

A
  • primary progressive
  • later
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Different clinical forms of MS

Clinically isolated syndrome (CIS)
- an initial episode of neurologic symptoms lasting over 24 hours
- involves ___ and ___ in the optic nerve, cerebrum, brainstem, or spinal cord
- most cases progress to MS

A

inflammation and demyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Different clinical forms of MS

progressive phase involved ___ (loss of myelin, axons, oligodendrocytes) and occurs with a similar rate in the different forms of MS

the overall clinical presentation is determined by the combination of the underlying ___ (uniform, progressive) and the host’s ___ reaction to it (intermittent, vaiable)

A

cytodegeneration
- degeneration, immune

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Autoimmune and degenerative phases

auto-immune phase
- antigens released from the ___or cross-reactive ___ antigens are presented to B and T cells in the lymph nodes
- B and T cells with high-affinity receptors for these antigens are expanded and migrate to CNS sites where they re-encounter and are activated by their target ligands
- activated B and T cells then carry out immune functions (release of antibodies and cytokines) at the __ sites

  • it is unclear which of the two phases is the disease trigger
A
  • CNS, foreign
  • CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Autoimmune and degenerative phases

  • CNS damage is triggered by activated B and T cells or by other insults such as ___ or ___
  • antigens released from damaged sites in the ___ further prime immune cells in the periphery, thus completing a vicious cycle
  • it is unclear which of the two phases is the disease trigger
A
  • infection, stroke
  • CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Autoimmune respinses in MS

  • ___ cells that present CNS antigens activate ___ -cell responses in the peripheral lymphoid tissue
  • activated B and T cells proliferate/infiltrate the CNS (involves ___ mediated binding and penetration of the BBB)
  • after re-encountering their specific antigen in the CNS, ___ cells mature to plasma cells and increase ___ antibodies that target the antigen on expressing cells (neurons)
  • ___ cells interact with their target ligands on oligodendrocytes, neurons, or microglia on MHC molecules
  • T cell activatioin results in ___ release and ___ stimulation, leading to damage to the myelin sheath
A
  • dendritic, T
  • a4-integrin
  • B, IgG
  • T
  • cytokine, macrophage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A closer look at autoimmune responses in MS

1) ___ T cells engage oligodendrocytes via T-cell receptor/mHC class I interactions
2) T cells release ___ , ___ , ___ , and ___ (leading to oligodendrocyte destruction)
3) antibodies trigger the activation of ___ (C5-9 membrane complex) on oligodendrocyte membranes resulting in ___ formation and cell damage
4) macrophages recruited to inflammatory lesion release toxic agents: ___ and ___ species, ___
5) macrophages also harm the ___ via phagocytosis

A

1) CD8
2) IFN-g, TNF-a, perforin, and granzyme
3) complement, pore
4) oxygen, nitrogen, glutamate
5) myelin sheath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

action potetnials in zones of demyelination

  • node of Ranvier = normal zone of ___
  • the node of Ranvier has voltage-gated ___ channels that are essential for replenishing actions potentials
  • in demyelinated regions of axons in MS, the propagation of the action potential is ___
  • the amount of current generated at the node of Ranvier is insufficient to fully ___ the demyelinated region because current is lost through the membrane
A
  • demyelination
  • Na
  • slowed
  • depolarize
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Repair via remyelination

remyelination involves the recruitment of ___ to the lesion and the differentiation of these cells into myelin-producing ___
- typically fails in MS because of a lack of ___ or failure for them to differentiate

___ involves the invasion and propagation of astrocytes resulting in the irreversible formation of gliotic plaques or scars

A

OPCs
oligodendrocytes
oligodendrocytes
astrogliosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

remyelination

  • demyelination (loss of myelin and ___ ) results in the activation of ___ and ___
  • once activated, they release pro-migratory factors and mitogens that recruit ___ to the lesion and stimulate their proliferation.
  • ___ eliminate the myelin debris
  • differentiation occurs via a process involving axon engagement and myelin sheath formation.
  • ____ is the key step where remyelination fails in MS
A
  • oligodendrocytes
  • microglia, astrocytes
  • OPCs
  • macrophages
  • differentiation
17
Q

demyelinated axons undergo remyelination of degeneration

remyelination fails in MS because of ongoing ___ . and demyelinated axons and neurons undergo degeneration

A

inflammation

18
Q
A

D) A and B

19
Q

Rationale for MS therapies

immunomodulatory therapies
- interference with T or B cell ___
- inhibitions of T or B cell ___ and ___ into the CNS
- inhibition of ___ mediated binding and penetration of the BBB, ___ breakdown of the BBB

rescue strategies
- ___ (agents that facilitate OPC recruitment or promote OPC differentiation)

A
  • activation
  • proliferation, movement
  • a4-integrin, enzymatic
  • remyelination
20
Q

Gadolinium

gadolinium is a contrast agent for MRI analysis
- penetrates the brain in regions where the BBB is ___
- MS lesions that exhibit enhancement after administration are considered ___ lesions
- over time, lesions observed by gadolinium enhanced MRI may grow or recede depending on how active the disease process is

A
  • compromised
  • active
21
Q

Guillain-Barre syndrome

  • acute, ___ neuropathy
  • preceded by a GI or respiratory ___ in about half of patients

symptoms
- weakness that begins in distal muscles and lower extremities, ascends to proximal muscles and upper extremities
- can progress to total ___ with death from respiratory failure in days
- progression peaks at 10-14 days

A
  • inflammatory
  • infection
  • paralysis
22
Q

Guillain-Barre syndrome

pathophysiology
- autoimmine attack on ___ nerves by circulating ___ , resulting in demyelination

treatment
- ventilation
- plasmapheresis (to eliminate auto - ___)
- IV immunoglobulin administration

prongnosis
- slow recovery (months to a year)
- fatalities can result from respiratory failure or ___
- most surviving patients recover completely, and the remaider have minor ___ deficits

A
  • peripheral, antibodies
  • antibodies
  • infection
  • motor
23
Q

Genetic influences of MS risk

  • about 5% of cases are familial
  • risk is highest in twins and siblings, lower in children and half siblings
  • these observations point to an exposure to some common ___ factor in childhood
  • alernatively, they suggest a role for one or more ___
  • ___ mode of ___ - genomic screens suggest that > 50 genomic regions may be linked to MS
A
  • environmental
  • genes
  • polygenic, inheritance
24
Q

Genetic influences of MS risk

genes linked to MS encode the following immune-related proteins:
- ___ : HLA DR15/DR6
- interleukin ___ receptor
- interleukin ___ receptor

25
# Clinically isolated syndrome (CIS) - initial episode of neurologic symptoms lasting more than ___ hours - involved ___ and ___ in the optic nerve, cerebrum, cerebellum, brainstem, or spinal cord (one or more foci) - **___ bands in cerebrospinal fluid (CSF)** - most cases progress to MS
- 24 - inflammation, demyelination - oligoclonal
26
# Marbug variant of MS - agressive form of MS involving a high degree of ___ - may resemble a brain tumor (high load of ___ ) in a brain scan
- inflammation - lesions
27
# Different clinical forms of MS **___ phase involves cytodegeneration (loss of myelin, axons, oligodendrocytes) and occurs with a similar rate in the different forms of MS** | see thick blue line in graphs
progressive | see thick blue line in graphs
28
# Different clinical forms of MS **the overall clinical presentation is determined by the combination of the underlying ___ (uniform, progressive) *and* the host's ___ reaction to it (intermittent, variable)** | see dashed blue/orange lines on graph
degeneration, immune
29
# pathophysiology of MS ___ results in a redistribution of voltage-gated ___ channels - in healthy neurons, ___ channels are located under the myelin sheath in internodal regions, wherease ___ channels are predominantly found in the nodes of Ranvier - in demyelinated axons, Na channels now accumulate in ___ regions from which they were previously excluded - **dysregulated ___ channel expression may play a role in disrupting the ___ properties of the axon and in neurondegeneration**
demyelination, Na - K, Na - internodal - Na, conductive
30
demyelinated axons can undergo ___ - myelin sheaths that result from remyelination are ___ and ___ , but allow for partial functional recovery
remyelination - thinner, shorter
31
# Patho of MS 1) ___ T cell MHC class I interaction leads to ___ / ___ release 2) ___ release by glial cells activates ___ receptors 3) ___ - antigen interactions causes ___ activation and formation of membrane disrupting TCC 4) release of ___ from macrophages, microglia, and astrocytes leads to inflammation, neuro ___ / ___ 5) ___ release by glial cells and ___ T cells lead to neuro ___ and ___ 6) migration of neuronal ___ cells and OPCs to the lesion causes ___ of damaged neurons and oligodendrocytes
1) CD8, cytokine/granule 2) glutamate, NDMA 3) antibody, complement 4) cytokines, protection, degeneration 5) neurotrophin, CD4, protection, regeneration 6) stem, replacement
32
# opportunities for therapeutic intervention in MS immune system targets - T cell ___ /penetration of ___ - T cell / ___ interactions - cytokines targets involved in remyelination - facilitate OPC ___ - promote OPC ___
- binding, BBB - APC - recruitment - differentiation
33
# drug examples - immune system targets T cell binding / penetration of BBB (2)
- a4-integrin antibodies - IFN-B
34
# drug examples - immune system targets T cell / APC interactions (2)
- altered peptide ligands (APLs) such as copaxon - statins
35
# drug examples - immune system targets cytokines (2)
- antibodies specific for IL-23 - osteopontin